arsenic has been researched along with Lupus Erythematosus, Systemic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, E; Hu, H; Li, Y; Zhang, T; Zhu, X | 1 |
| Huang, H; Mu, Z; Qiao, Z; Shan, S; Sun, Q; Wen, G; Xu, H; Zhang, J; Zhao, Y | 1 |
| Bobé, P; Chelbi-Alix, MK | 1 |
| HYMAN, AB | 1 |
| SONNECK, HJ | 1 |
| Benihoud, K; Bobé, P; Bonardelle, D; Chelbi-Alix, MK; Opolon, P | 1 |
| Lin, SX; Xia, XR; Zhou, Y | 1 |
| BIRCHALL, R; CHRISTIANSON, HB | 1 |
8 other study(ies) available for arsenic and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Effects of Arsenic Trioxide on INF-gamma Gene Expression in MRL/lpr Mice and Human Lupus.
Topics: Adult; Animals; Arsenic Trioxide; Arsenicals; Cells, Cultured; Female; Gene Expression; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Male; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Oxides; Spleen; Young Adult | 2018 |
Effects of tetra-arsenic tetra-sulfide on BXSB lupus-prone mice: a pilot study.
Topics: Animals; Antibodies, Antinuclear; Arsenic; Arsenicals; Hair; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Pilot Projects; Spleen; Splenomegaly; Sulfides | 2013 |
[New therapeutic perspectives for arsenic: from acute promyelocytic leukemia to autoimmune diseases].
Topics: Animals; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Autoimmune Diseases; Disease Models, Animal; Growth Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Mice; Oxides | 2008 |
Oxophenarsine hydrochloride in treatment of lupus erythematosus.
Topics: Antiprotozoal Agents; Arsenicals; Humans; Lupus Erythematosus, Systemic | 1946 |
[Erythematosus discoides chronicus with exacerbation by spirocid].
Topics: Arsenic Poisoning; Arsenicals; Humans; Lupus Erythematosus, Systemic | 1952 |
Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cytokines; Drug Evaluation, Preclinical; Enzyme Activation; fas Receptor; Glutathione; Humans; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphoproliferative Disorders; Mice; Mice, Inbred MRL lpr; Nitric Oxide; Oxidation-Reduction; Oxides; Syndrome | 2006 |
[Effects of arsenic trioxide on the autoimmunity and survival time in BXSB lupus mice].
Topics: Animals; Antibodies, Antinuclear; Arsenic Trioxide; Arsenicals; Autoimmunity; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Injections, Intraperitoneal; Interferon-gamma; Kidney; Lupus Erythematosus, Systemic; Mice; Oxides; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen; Survival Analysis | 2007 |
NEPHROCUTANEOUS SYNDROMES.
Topics: Amyloidosis; Anemia; Anemia, Sickle Cell; Angiokeratoma; Arachnodactyly; Arsenic; Blood Protein Disorders; Collagen Diseases; Dermatology; Drug Hypersensitivity; Ehlers-Danlos Syndrome; Glomerulonephritis; Humans; Kidney Diseases; Leukemia; Lupus Erythematosus, Systemic; Marfan Syndrome; Metabolic Diseases; Multiple Myeloma; Neurofibromatoses; Pseudoxanthoma Elasticum; Purpura; Pyelonephritis; Skin Neoplasms; Toxicology; Tuberous Sclerosis; Vascular Diseases | 1964 |